A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Health Catalyst, Inc.
HCAT
$145M
Mkt Cap
$2.08
+3.48%
Health Catalyst, Inc. (HCAT) has a 5-year average return on invested capital (ROIC) of -23.5%. This is below average and may indicate limited pricing power.
Health Catalyst, Inc. (HCAT) has a market capitalization of $145M. It is classified as a small-cap stock.
Health Catalyst, Inc. (HCAT) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 3.44%.
Health Catalyst, Inc. (HCAT) operates in the Services-Computer Programming, Data Processing, Etc. industry, within the Technology sector.
Health Catalyst, Inc. (HCAT) reported annual revenue of $311 million in its most recent fiscal year, based on SEC EDGAR filings.
Health Catalyst, Inc. (HCAT) has a net profit margin of -57.2%. The company is currently unprofitable.
Health Catalyst, Inc. (HCAT) generated $-237 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Health Catalyst, Inc. operates in the Services-Computer Programming, Data Processing, Etc. industry, Technology sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 311M | 311M | 307M | 296M | 276M | 242M |
| Net Income | -178M | -178M | -70M | -118M | -137M | -153M |
| EPS | $-2.55 | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 |
| Free Cash Flow | -237K | -237K | 13M | -34M | -37M | -34M |
| ROIC | -34.7% | -39.0% | -12.5% | -19.0% | -20.3% | -26.7% |
| Gross Margin | 48.7% | 48.7% | 45.9% | 44.5% | 48.2% | 48.6% |
| Debt/Equity | 0.70 | 0.70 | 1.10 | 0.68 | 0.58 | 0.39 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -161M | -161M | -70M | -127M | -140M | -144M |
| Operating Margin | -51.7% | -51.7% | -22.8% | -42.9% | -50.7% | -59.4% |
| ROE | -72.4% | -58.3% | -19.0% | -29.8% | -29.0% | -38.4% |
| Shares Outstanding | 70M | 70M | 60M | 57M | 52M | 47M |
| Metric | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 73M | 113M | 155M | 189M | 242M | 276M | 296M | 307M | 311M | 311M |
| Gross Margin | 40.3% | 46.8% | 51.4% | 48.1% | 48.6% | 48.2% | 44.5% | 45.9% | 48.7% | 48.7% |
| R&D | 28M | 39M | 46M | 54M | 63M | 76M | 73M | 58M | 50M | 50M |
| SG&A | 15M | 23M | 32M | 59M | 86M | 62M | 77M | 57M | 50M | 50M |
| EBIT | -46M | -60M | -55M | -96M | -144M | -140M | -127M | -70M | -161M | -161M |
| Op. Margin | -62.3% | -53.4% | -35.4% | -50.9% | -59.4% | -50.7% | -42.9% | -22.8% | -51.7% | -51.7% |
| Net Income | -59M | -114M | -241M | -115M | -153M | -137M | -118M | -70M | -178M | -178M |
| Net Margin | -80.4% | -101.3% | -155.5% | -60.9% | -63.3% | -49.7% | -39.9% | -22.7% | -57.2% | -57.2% |
| Non-Recurring | 47K | 29K | 39K | 0 | 0 | 0 | 0 | 0 | 105M | 105M |
| Returns on Capital | ||||||||||
| ROIC | N/M | -54.2% | -26.5% | -33.1% | -26.7% | -20.3% | -19.0% | -12.5% | -39.0% | -34.7% |
| ROE | 25.2% | 36.0% | 276.7% | -48.3% | -38.4% | -29.0% | -29.8% | -19.0% | -58.3% | -72.4% |
| ROA | -1306.2% | -197.5% | -116.6% | -26.1% | -21.7% | -17.3% | -16.3% | -8.9% | -26.1% | -35.4% |
| Cash Flow | ||||||||||
| Op. Cash Flow | -37M | -40M | -32M | -26M | -23M | -35M | -33M | 15M | 731K | 731K |
| Free Cash Flow | -39M | -42M | -34M | -34M | -34M | -37M | -34M | 13M | -237K | -237K |
| Owner Earnings | -47M | -52M | -59M | -83M | -126M | -250M | -131M | -67M | -77M | -77M |
| CapEx | 2.5M | 2.1M | 2.0M | 7.8M | 10M | 2.2M | 1.2M | 1.6M | 968K | 968K |
| Maint. CapEx | 5.9M | 7.4M | 9.2M | 19M | 38M | 143M | 42M | 41M | 51M | 51M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 5.9M | 7.4M | 9.2M | 19M | 38M | 143M | 42M | 41M | 51M | 51M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 11.1% | N/A | 132.4% |
| Capital Allocation | ||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 8.7M | 0 | 0 | 0 | 8.4M | 1.8M | 0 | 5.0M | 5.0M |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | 1.6% | 0.3% | N/A | 0.0% | 3.4% |
| Stock-Based Comp | 4.2M | 4.2M | 18M | 38M | 65M | 72M | 56M | 40M | 27M | 27M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||||
| Net Debt | N/A | 15M | -126M | -76M | -240M | -116M | -69M | 10M | 76M | 120M |
| Cash & Equiv. | 23M | 28M | 18M | 92M | 193M | 116M | 106M | 250M | 51M | 51M |
| Long-Term Debt | N/A | 19M | 48M | 169M | 181M | 227M | 228M | 151M | 152M | 152M |
| Debt/Equity | -1.02 | -0.13 | 0.51 | 0.71 | 0.39 | 0.58 | 0.68 | 1.10 | 0.70 | 0.70 |
| Interest Coverage | -44.1 | -15.3 | -9.9 | -19.3 | -22.6 | -24.3 | -22.1 | -6.9 | -7.3 | -7.3 |
| Equity | -259M | -375M | 201M | 276M | 522M | 425M | 367M | 365M | 246M | 246M |
| Total Assets | 4.5M | 111M | 302M | 578M | 832M | 752M | 702M | 859M | 503M | 503M |
| Total Liabilities | 264M | 76M | 102M | 302M | 310M | 327M | 335M | 494M | 257M | 257M |
| Intangibles | N/A | 28M | 26M | 99M | 105M | 92M | 73M | 86M | 78M | 78M |
| Retained Earnings | N/A | -375M | -611M | -726M | -879M | -999M | -1.1B | -1.2B | -1.4B | -1.4B |
| Working Capital | N/A | 25M | 216M | 242M | 415M | 345M | 304M | 140M | 80M | 80M |
| Current Assets | N/A | 67M | 264M | 330M | 508M | 428M | 393M | 466M | 169M | 169M |
| Current Liabilities | N/A | 42M | 48M | 88M | 93M | 83M | 89M | 326M | 90M | 90M |
| Per Share Data | ||||||||||
| EPS | -12.13 | -23.76 | -12.86 | -2.91 | -3.23 | -2.63 | -2.09 | -1.15 | -2.55 | -2.55 |
| Owner EPS | -9.69 | -10.82 | -3.16 | -2.10 | -2.65 | -4.79 | -2.32 | -1.11 | -1.10 | -1.10 |
| Book Value | -53.55 | -78.10 | 10.71 | 6.99 | 11.01 | 8.14 | 6.49 | 6.04 | 3.52 | 3.52 |
| Cash Flow/Share | -7.60 | -8.40 | -1.72 | -0.66 | -0.49 | -0.68 | -0.59 | 0.24 | 0.01 | -1.83 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 4.8M | 4.8M | 18.7M | 39.5M | 47.4M | 52.2M | 56.5M | 60.4M | 69.8M | 69.8M |
| Valuation | ||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.8 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 33.1 | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | 3.2 | 6.4 | 3.6 | 1.2 | 1.5 | 1.2 | N/A | 0.6 |
| Price/Sales | N/A | N/A | 4.3 | 6.7 | 9.9 | 3.3 | 2.1 | 1.5 | N/A | 0.5 |
| FCF Yield | N/A | N/A | -5.3% | -1.9% | -1.8% | -7.2% | -6.3% | 3.0% | N/A | -0.2% |
| Market Cap | 0 | N/A | 640M | 1.8B | 1.9B | 518M | 541M | 428M | 0 | 145M |
| Avg. Price | 0.00 | N/A | 35.78 | 32.17 | 50.49 | 17.43 | 11.18 | 7.68 | 0.00 | 2.08 |
| Year-End Price | 0.00 | N/A | 34.14 | 44.74 | 39.59 | 9.92 | 9.57 | 7.08 | 0.00 | 2.08 |
Health Catalyst, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 47.2%. Total shareholder yield (buybacks) is 3.4%.
Health Catalyst, Inc. (HCAT) has a debt-to-equity ratio of 0.70. This indicates moderate leverage.
Health Catalyst, Inc. (HCAT) reported earnings per share (EPS) of $-2.55 in its most recent fiscal year.
Health Catalyst, Inc. (HCAT) has a return on equity (ROE) of -58.3%. A negative ROE may indicate losses or negative equity.
Health Catalyst, Inc. (HCAT) has a 5-year average gross margin of 47.2%. This indicates decent pricing power.
The Ledger Terminal provides 9 years of financial data for Health Catalyst, Inc. (HCAT), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Health Catalyst, Inc. (HCAT) has a book value per share of $3.52, based on its most recent annual SEC filing.